teins and regulation. The resolution of the genetic map grew rapidly as did its annotation. Laboratories all over the world were into genetics from gene conversion to working out the dedicated metabolic pathways. About this time, however, Lee Hartwell began dissecting a much more sophisticated system using temperature-sensitive (TS) mutants-the cell division cycle (Hartwell 1967; Hartwell, Culotti and Reid 1970) . Hartwell was not first to discover TS mutants in yeast, but his fascinating results launched the broad use of these mutants to investigate cellular processes rather than products. Yeast became the perfect organism with which to investigate complicated eukaryotic cell biology.
Most of the early work in cell biology depended on easily assayable cellular process such as budding or an enzyme such as histidinol dehydrogenase, the HIS4 gene product. With pathway steps being worked out and assays available, regulation became the focus, but only at the enzyme level. Bacteriophages, especially lambda, and its use to isolate specific genes, e.g. lacZ, provided bacteria with a competitive edge for investigating transcriptional control. That edge was short lived, however, when Ron Davis reported at the Schliersee (1976) international conference that yeast genes could be cloned in lambda as well (Struhl, Cameron and Davis 1976) . Cloning in yeast was off and running but not yet broadly used in the community. To achieve that status, two additional technological developments were required: successful transformation of yeast in Gerry Fink's lab (Hinnen, Hicks and Fink 1978) , and the isolation of a replication origin on the Trp1-EcoR1 fragment and efficient cloning by complementation in John Carbon's lab (Kingsman et al. 1979; Hsiao and Carbon 1979) . These technological leaps put cloning into the hands of the entire community and yeast investigators started cloning everything in sight, or at least any gene for which they had mutants.
Maxam-Gilbert chemical DNA sequencing became available about this time, the next quantum leap in technology. Broad use of DNA sequencing was a bit slow at the beginning because chemical sequencing wasn't easy to perform. Sanger sequencing was available, but it often didn't work. Here the critical component was the appearance of commercial 'Kits'. Sanger sequencing didn't often work because folks didn't weigh out the nucleotides with sufficient care. With 'Kits', it worked. Sequencing was easy and the rush was on to get one's genes sequenced. Tracking back through the literature there were waves of papers demonstrating the restriction maps of cloned genes and the use of the plasmid-borne gene to measure its expression. This was followed by a wave of DNA sequencing papers. The sequencing C FEMS 2017. All rights reserved. For permissions, please e-mail: journals.permissions@oup.com wave would have continued for some time, but it was somewhat shortened by one of the most impressive collaborations in biological research, sequencing of the entire yeast genome, its completion announced in 1996 (Goffeau et al. 1996) . Andre Goffeau was a central figure in this enterprise. All of the previous genetic and locus/function mapping work became the basis for rapid annotation, an unfinished task with many genes of unknown function remaining to this day. DNA sequences were the foundation for the next wave of discovery, promoter analysis or promoter bashing as it became known, initiated by Lenny Guarente's expression of the lacZ gene under control of the CYC1 promoter (Guarente and Ptashne 1981) . New promoter elements were being reported monthly along with components of the RNA polymerase core and mediator-type complexes. Chromatin structure and remodeling were also recognized as important components of transcriptional regulation.
The waves of biological discovery, however, centered on one's favorite gene or group of genes, group meaning not very many. Imagination again took over leading to the question, wouldn't it be great if we could assay expression of the entire genome in one fell swoop? First on spotted membranes and through collaboration between Stanford University and ABI, the now famous 'Chip' was born and transcriptome analyses permitted an entirely new way of investigating cellular regulation. Again, however, there was a lag before this wave of technology became mainstream, mainly because 'Chips' were too expensive for most laboratories to use them. Broad-based transcriptome analyses awaited the appearance of 'slides' developed by Pat Brown and Ron Davis in which genome probes were printed onto microscope slides (Schena et al. 1995) . The two approaches could generate more data in a few days than all of the previously collected transcription data in the literature. Almost unimaginable amounts of data became available. Data, much of which, we're still trying to figure out.
We gained an increasing understanding of regulated-cellular component production, but it took a jelly fish and GFP for us to see the light and those components' locations. GFP fluorescence and the power it afforded gave rise to a palette of colored fluorescent and other protein tags whose use Erin O'Shea described in detail at workshops in each yeast meeting and followed by their broad distribution. It then became fashionable to locate your favorite protein and a wave of tagged protein papers appeared in the literature. Tags also made it possible to pull down specific proteins, an important prerequisite for following post-translational modifications which abounded along with protein-protein interaction experiments in yet another wave of discovery. Pull downs worked well for a few proteins, but weren't scalable. Pioneered by Fields and Song (1989) , two-hybrid assays successfully met the challenge. Fields', Brenda Andrew's, Charlie Boone's and other labs developed the genome-wide interactome (Costanzo et al. 2016) . The metabolome, epigenome and other 'omes' are well on their way to routine use. Analyzing and assembling these 'omic' data to understand integrated biological processes has led to development of a completely new discipline, systems biology in which yeast has been a major contributor.
As the wave of discoveries pushed on, so too did the number of investigators riding them and the number of Nobel prizes derived from all of that exciting research, 5 since 2001. But like a closed cell culture, exponential growth cannot go on indefinitely. Saccharomyces has recently begun to feel the constraints of limiting resources elicited by the increased number and cost of experiments and shifts in the political landscape reflected in funding agencies' priorities. This basic science stuff was all well and good, but today's legislators are more interested in concrete products to which their constituents can relate, increased biofuels, biogenerated chemicals, cures for chronic diseases, etc. Further, another technological discovery engaged and excited the overall scientific community, knock in and out mice and CRISPR-Cas9 (Jinek et al. 2012; Cong et al. 2013 ). This technological wave, however, did not involve yeast, but mammalian cells. Yeast's greatest competitive advantage over higher eukaryotic cells, i.e. its powerful genetics and comprehensive library of knowledge, has begun to erode. Faced with these pressures, yeast investigators began incorporating higher organism cell studies into their work or shifting their focus more towards commercially supportable discoveries. International Yeast Genetics and Molecular Biology Conference attendance leveled off at 400 to 700 after 2003 prompting the community to begin asking is Saccharomyces discovery moving into its last phase of growth, starvation and stationary phase.
It is my hope and view that although the numbers of yeast investigators will not continue to increase in the foreseeable future and funding may remain restrictive, Saccharomyces will morph into a new phase of growth again fueled by its simplicity and its convenient manipulation. Greater effort will be devoted to engineering yeast metabolism for the production of fuels and chemicals which in turn will support the need for greater basic knowledge. The major constraint will be our curiosity and imagination. The past five and a half decades have been devoted to parsing cells into their component parts. In retrospect that was the easy part. The hard part will be truly reassembling the cell components-the 'omics' data-back together again, answering the enormously complex questions of how do all of these 'omics' work together to project a lowly yeast cell so successfully through rapidly changing environments from one generation to the next. The same question can be asked of human cells, but it's immeasurably more complex. Most human cells are contained within organs, within the human organism and it will likely be necessary to understand a single yeast cell before a human consisting of 37 trillion cells, give or take depending on the mode of estimation, is reconstructed at the same resolution of understanding. Case in point, synthesizing a eukaryotic genome. It hasn't been achieved in Hela or some other human cell line, but soon will be achieved in the cell of bread, wine and beer fame. Like Saccharomyces itself, we who investigate it must adapt to changing environments and in so doing will retain our viability and vitality as will the International Community of Yeast Genetics and Cell Biology (http://www.yeast2017.cz).
